Trial
NCT04039347
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Zambon SpA
Collaborators
—
Condition
Bronchiolitis Obliterans
Intervention
Liposomal Cyclosporine A 5 mg
Why stopped
Study was terminated for business reasons. The earlier study end is not related to any safety concerns or data issues identified at any site or within the overall study data collected to date.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-07